The largest community of pharma leaders

OncoCell MDx Appoints Marc Stapley to its Board of Directors

ROYAL OAK, Mich.–(BUSINESS WIRE)–#OncoCellMDx–OncoCell MDx, an immunogenomics platform company developing novel, noninvasive molecular diagnostic assays for cancer and other disease, today announced that Marc Stapley has joined the company’s Board of Directors. “I am excited to have Marc Stapley join the OncoCell Board of Directors. Marc brings a wealth of relevant experience as an executive and a board member to our team, including a track record of growing and transforming companies in the genomics and…

 

 

http://www.businesswire.com/news/home/20190725005212/en/OncoCell-MDx-Appoints-Marc-Stapley-Board-Directors

Recent Articles

Gyroscope Therapeutics Granted FDA Fast Track Designation for GT005, an Investigational Gene Therapy for Dry Age-Related Macular Degeneration

LONDON--(BUSINESS WIRE)-- #GeneTherapy--Gyroscope Therapeutics Granted FDA Fast Track Designation for GT005,...

Medeor Therapeutics’ Transplant Immune Tolerance Therapy Receives Regenerative Medicine Advanced Therapy Designation from FDA

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Medeor announces that the FDA has granted...

FDA Sued for Ignoring Petition Calling for Breast Cancer Warning Labels on Cheese

WASHINGTON--(BUSINESS WIRE)--The Physicians Committee for Responsible Medicine filed a lawsuit on...
2020 Call for Writers

Are you looking to inspire others in the pharma industry through your writing? You’re invited to submit your articles to become a Featured Writer for The Pharmaceutical Marketing Group website.